Special Warning : אזהרת שימוש

4.4 Special warnings and precautions for use
The likelihood of systemic side effects occurring following the topical application of Sunactic is very small compared to the frequency of side effects with oral diclofenac, owing to low systemic absorption with Sunactic. However, the possibility of systemic adverse events from application of topical diclofenac cannot be excluded if the preparation is used on large areas of skin and over a prolonged period (see product information on systemic forms of diclofenac). This product should be used with caution in patients with a history of and/or active gastrointestinal ulceration or bleeding, or reduced heart, liver or renal function, since isolated cases of systemic adverse reactions consisting of renal affection, has been reported with topically administered antiphlogistics.
It is known that nonsteroidal anti-inflammatory drugs (NSAIDs) can interfere with platelet function. Although the likelihood of systemic side effects is very low, caution should be used in patients with intracranial hemorrhage and bleeding diathesis.
Direct sunlight, including solarium, should be avoided during treatment. If sensitivity skin reactions occur, discontinue use.
Sunactic should not be applied to skin wounds, infections or exfoliative dermatitis. It should not be allowed to come into contact with the eyes or mucous membranes and should not be ingested.
Discontinue the treatment if a generalised skin rash develops after applying the product.
Topical diclofenac can be used with non-occlusive bandages but should not be used with an airtight occlusive dressing.
This medicine contains 10 mg benzyl alcohol in each g. Benzyl alcohol may cause allergic reactions and mild local irritation.

Effects on Driving

4.7 Effects on ability to drive and use machines
Cutaneous application of topical diclofenac has no influence on the ability to drive and use machines.